Rohto Pharmaceutical. (4527.TSE) Q2 2025 Earnings

13MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
21
31
41
51

Details

Expected EPS
25
Actual EPS
27
Surprise EPS
2
Surprise Percent
+9.7%

Description

Rohto Pharmaceutical. (4527.TSE) has reported earnings of 27 per share for Q2 2025.

0 Comments

Share your thoughts